Group One Trading’s Treace Medical Concepts TMCI Stock Holding History

Group One Trading’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.96K	Buy	+2,000	New	+$5.5K	﹤0.01%	6540
2026 Q1	–	Sell	-4,000	Closed	-$9.8K	–	8757
2025 Q4	$9.8K	Buy	4,000 +3,500	+700%	+$15.2K	﹤0.01%	6819
2025 Q3	$3.35K	Buy	+500	New	+$3.27K	﹤0.01%	7728
2024 Q4	–	Sell	-82,000	Closed	-$476K	–	7972
2024 Q3	$476K	Hold	82,000	–	–	﹤0.01%	2885
2024 Q2	$545K	Buy	82,000 +47,700	+139%	+$385K	﹤0.01%	2481
2024 Q1	$448K	Sell	34,300 -129,900	-79%	-$1.73M	﹤0.01%	2847
2023 Q4	$2.09M	Buy	+164,200	New	+$1.66M	0.01%	1837
2023 Q2	–	Sell	-900	Closed	-$22.7K	–	8213
2023 Q1	$22.7K	Sell	900 -14,100	-94%	-$331K	﹤0.01%	5418
2022 Q4	$345K	Buy	+15,000	New	+$345K	﹤0.01%	3372

Other funds holding TMCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Group One Trading's TMCI Position: Q2 2026 in Review

Group One Trading increased its Treace Medical Concepts (TMCI) stake by 155% in Q2 2026, buying an estimated $25.3K and bringing the position to 15,147 shares worth $60.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5254.

Group One Trading first reported a position in TMCI in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.61M in Q4 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

Group One Trading held 15,147 shares of Treace Medical Concepts worth $60.3K as of Q2 2026.
Group One Trading bought 9,208 Treace Medical Concepts shares in Q2 2026, an estimated $25.3K.
Treace Medical Concepts made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5254 holding.
Group One Trading first reported a position in Treace Medical Concepts in Q4 2023 and has held it in 9 quarters since.
Group One Trading's Treace Medical Concepts position peaked at $1.61M in Q4 2023.
116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.